SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-258490
Filing Date
2023-10-18
Accepted
2023-10-18 16:15:30
Documents
15
Period of Report
2023-10-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d331798d8k.htm   iXBRL 8-K 34965
2 EX-3.1 d331798dex31.htm EX-3.1 8270
3 EX-99.1 d331798dex991.htm EX-99.1 9633
7 GRAPHIC g331798g1018065816713.jpg GRAPHIC 6168
  Complete submission text file 0001193125-23-258490.txt   196673

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nexi-20231017.xsd EX-101.SCH 2828
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20231017_lab.xml EX-101.LAB 18725
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20231017_pre.xml EX-101.PRE 11690
9 EXTRACTED XBRL INSTANCE DOCUMENT d331798d8k_htm.xml XML 3596
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 231332417
SIC: 2834 Pharmaceutical Preparations